Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preview: Lyme disease vaccines.

E F Donnelly1

  • 1Office of Communicable Diseases, Rhode Island Department of Health, USA.

Medicine and Health, Rhode Island
|December 8, 2004
PubMed
Summary
This summary is machine-generated.

New Lyme disease vaccines show promise for Rhode Island residents, appearing safe and effective in human trials. Public demand is expected, particularly in high-risk southern areas, but awareness of other tick-borne illnesses is crucial.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of manual and automatic segmentation methods for brain structures in the presence of space-occupying lesions: a multi-expert study.

Physics in medicine and biology·2011
Same author

Utilization of inpatient rehabilitation services.

Medicine and health, Rhode Island·2002
Same author

Risk factors for syphilis among incarcerated women in Rhode Island.

AIDS patient care and STDs·2002
Same author

Psychological impact of news of genetic risk for Huntington disease.

American journal of medical genetics·2001
Same author

Complications of anesthesia.

Medicine and health, Rhode Island·2001
Same author

Trends in asthma hospitalizations in Rhode Island.

Medicine and health, Rhode Island·2001
Same journal

Physician's lexicon. A proliferation of pro- words.

Medicine and health, Rhode Island·2013
Same journal

For whom does the cricket sing?

Medicine and health, Rhode Island·2013
Same journal

Hospital emergency department visits for non-traumatic oral health conditions among Rhode Island adults age 21-64 years, 2006-2010.

Medicine and health, Rhode Island·2013
Same journal

Staying healthy during hard times: the impact of economic distress on accessing care and chronic disease management.

Medicine and health, Rhode Island·2013
Same journal

Eligibility for financial incentives and electronic medical record use among physicians.

Medicine and health, Rhode Island·2013
Same journal

Cubital tunnel syndrome: diagnosis and management.

Medicine and health, Rhode Island·2013
See all related articles

Area of Science:

  • Infectious Diseases
  • Vaccinology
  • Public Health

Background:

  • Lyme disease is a prevalent tick-borne illness in Rhode Island.
  • Existing Lyme disease vaccines have demonstrated efficacy in animal models.
  • Two manufacturers have conducted human trials for an OspA-based Lyme disease vaccine.

Purpose of the Study:

  • To evaluate the safety and efficacy of a new OspA-based Lyme disease vaccine.
  • To assess the potential demand for Lyme disease vaccination in Rhode Island.
  • To inform public health strategies regarding Lyme disease prevention and management.

Main Methods:

  • Human clinical trials involving thousands of participants.
  • Analysis of vaccine safety and efficacy data.
  • Assessment of tick population studies and disease surveillance data.

Related Experiment Videos

Main Results:

  • The Lyme disease vaccines appear to be safe and effective in human trials.
  • Strong demand for the vaccine is anticipated in Rhode Island, especially in southern regions.
  • Tick surveillance indicates a concentration of Lyme disease risk in Washington County, with inland expansion.

Conclusions:

  • The OspA-based Lyme disease vaccines are a promising development for public health in endemic areas.
  • Physicians should educate patients on potential local and systemic reactions, as well as other tick-borne diseases.
  • Serologic testing for Lyme disease may be impacted by vaccine-induced immune responses; vaccines are not yet tested in children.